NATALIA HEDGES: Open Payments
NPI 1881268514 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 31 payments from 17 companies in 2025. Trend: 2023 $107 · 2024 $271 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $66 |
| Lilly USA, LLC | 4 | $64 |
| Tris Pharma Inc | 1 | $62 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| ABBVIE INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| SI-BONE, INC. | 1 | $15 |
Products named: CAPLYTA, JARDIANCE, NURTEC ODT, Dyanavel XR, Sunosi, MOUNJARO, VRAYLAR, ROTATEQ.
Industry payments across UT — which companies pay providers there.
